These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32519990)

  • 1. The long-term safety and efficacy of fibrates in patients with hypertriglyceridemia: Real-life data from a lipid clinic cohort.
    Zambon A
    Turk Kardiyol Dern Ars; 2020 Jun; 48(4):357-358. PubMed ID: 32519990
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
    Ito MK
    Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy of fibrates on hypertriglyceridemic phenotypes with different genetic and clinical characteristics.
    Brisson D; Méthot J; Tremblay K; Tremblay M; Perron P; Gaudet D
    Pharmacogenet Genomics; 2010 Dec; 20(12):742-7. PubMed ID: 21217359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events.
    McCullough PA; Ahmed AB; Zughaib MT; Glanz ED; Di Loreto MJ
    Rev Cardiovasc Med; 2011; 12(4):173-85. PubMed ID: 22249508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrates: their prescription must be restricted].
    Béliard-Lasserre S
    Rev Prat; 2015 Dec; 65(10):1243-4. PubMed ID: 26979011
    [No Abstract]   [Full Text] [Related]  

  • 6. [Update: clinical lipidology].
    Parhofer KG
    MMW Fortschr Med; 2013 Jul; 155(13):49-52; quiz 53-4. PubMed ID: 23964509
    [No Abstract]   [Full Text] [Related]  

  • 7. Triglyceride levels, pancreatitis and choice of lipid-modifying therapy.
    Preiss D
    Expert Rev Gastroenterol Hepatol; 2013 Mar; 7(3):193-5. PubMed ID: 23445227
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrates and fish oil, but not corn oil, up-regulate the expression of the cholesteryl ester transfer protein (CETP) gene.
    Raposo HF; Patrício PR; Simões MC; Oliveira HC
    J Nutr Biochem; 2014 Jun; 25(6):669-74. PubMed ID: 24746832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertriglyceridemia secondary to obesity and diabetes.
    Subramanian S; Chait A
    Biochim Biophys Acta; 2012 May; 1821(5):819-25. PubMed ID: 22005032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fibrates].
    Hara F; Yamazaki J
    Nihon Rinsho; 2013 Sep; 71(9):1643-8. PubMed ID: 24205728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations.
    Hamilton-Craig I; Kostner KM; Woodhouse S; Colquhoun D
    Int J Evid Based Healthc; 2012 Sep; 10(3):181-90. PubMed ID: 22925614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review and meta-analysis deciphering the impact of fibrates on paraoxonase-1 status.
    Sahebkar A; Hernández-Aguilera A; Abelló D; Sancho E; Camps J; Joven J
    Metabolism; 2016 May; 65(5):609-622. PubMed ID: 27085770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of fibrates on circulating cystatin C levels: a systematic review and meta-analysis of clinical trials.
    Sahebkar A; Simental-Mendía LE; Pirro M; Montecucco F; Carbone F; Banach M; Barreto GE; Butler AE
    Ann Med; 2018 Sep; 50(6):485-493. PubMed ID: 29957074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperlipidaemia and cardiovascular disease: do fibrates have a role?
    Saha SA; Arora RR
    Curr Opin Lipidol; 2011 Aug; 22(4):270-6. PubMed ID: 21519250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Introduction to drug therapy].
    Ishii H; Yoshida M
    Nihon Rinsho; 2013 Sep; 71(9):1636-40. PubMed ID: 24205727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine society releases guidelines on diagnosis and management of hypertriglyceridemia.
    Endocrine Society
    Am Fam Physician; 2013 Jul; 88(2):142-4. PubMed ID: 23939649
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs for hypertriglyceridemia.
    Med Lett Drugs Ther; 2013 Mar; 55(1411):17-9. PubMed ID: 23467119
    [No Abstract]   [Full Text] [Related]  

  • 18. Triglycerides and endothelial function: molecular biology to clinical perspective.
    Kajikawa M; Higashi Y
    Curr Opin Lipidol; 2019 Oct; 30(5):364-369. PubMed ID: 31348023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epanova(®) and hypertriglyceridemia: pharmacological mechanisms and clinical efficacy.
    Kataoka Y; Uno K; Puri R; Nicholls SJ
    Future Cardiol; 2013 Mar; 9(2):177-86. PubMed ID: 23463969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense Inhibition of Apolipoprotein C-III in Patients with Hypertriglyceridemia.
    Gaudet D; Alexander VJ; Baker BF; Brisson D; Tremblay K; Singleton W; Geary RS; Hughes SG; Viney NJ; Graham MJ; Crooke RM; Witztum JL; Brunzell JD; Kastelein JJ
    N Engl J Med; 2015 Jul; 373(5):438-47. PubMed ID: 26222559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.